Perivascular drainage of amyloid-β peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease

Brain Pathology

Volumn 18, Issue 2, 2008, Pages 253-266

  Weller, Roy O ^a,b   Subash, Malavika ^a   Preston, Stephen D ^a   Mazanti, Ingrid ^a   Carare, Roxana O ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid beta; Cerebral Amyloid Angiopathy; Cerebrovascular disease; Intracerebral hemorrhage; Perivascular drainage

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTERIAL STIFFNESS; ARTERY WALL; BASEMENT MEMBRANE; BRAIN ARTERY; BRAIN CAPILLARY; BRAIN HEMORRHAGE; COGNITION; CONFERENCE PAPER; HUMAN; INTERSTITIAL FLUID; LYMPHATIC DRAINAGE; METABOLITE; NEUROPATHOLOGY; NONHUMAN; SOLUTE; THEORETICAL MODEL; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CEREBRAL AMYLOID ANGIOPATHY; DRAINAGE; HUMANS;

EID: 41149157623     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2008.00133.x     Document Type: Conference Paper

References (106)

1. Abbott NJ (2004) Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 45 : 545 552.
2. Aird RB (1986) A study of intrathecal, cerebrospinal fluid-to-brain exchange. Exp Neurol 86 : 342 358.
3. Alcolado R, Weller RO, Parrish EP, Garrod D (1988) The cranial arachnoid and pia mater in man: anatomical and ultrastructural observations. Neuropathol Appl Neurobiol 14 : 1 17.
4. Alperin NJ, Lee SH, Loth F, Raskin PB, Lichtor T (2000) MR-intracranial pressure (ICP): a method to measure intracranial elastance and pressure noninvasively by means of MR Imaging: baboon and human study. Radiology 217 : 877 885.
5. Attems J, Quass M, Jellinger KA, Lintner F (2007) Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer's disease pathology. J Neurol Sci 257 : 49 55.
6. Beach TG, Kuo YM, Spiegel K, Emmerling MR, Sue LI, Kokjohn K, Roher AE (2000) The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer's disease. J Neuropathol Exp Neurol 59 : 308 313.
7. Beach TG, Potter PE, Kuo YM, Emmerling MR, Durham RA, Webster SD et al (2000) Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta deposition. Neurosci Lett 283 : 9 12.
8. Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, Deane R, Zlokovic BV (2007) Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27 : 909 918.
9. Bergsneider M (2001) Evolving concepts of Cerebrospinal Fluid. Neurosurg Clin N Am 36 : 631 638.
10. Bornebroek M, Haan J, Maat-Schieman ML, Van Duinen SG, Roos RA (1996) Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): I - A review of clinical, radiologic and genetic aspects. Brain Pathol 6 : 111 114.
11. Bornebroek M, Haan J, Backhovens H, Deutz P, Van Buchem MA et al (1997) Presenilin-1 polymorphism and hereditary cerebral hemorrhage with amyloidosis, Dutch type. Ann Neurol 42 : 108 110.
12. Boulton M, Flessner M, Armstrong D, Mohamed R, Hay J, Johnston M (1999) Contribution of extracranial lymphatics and arachnoid villi to the clearance of a CSF tracer in the rat. Am J Physiol 276 : R818 R823.
13. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82 : 239 259.
14. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 112 : 389 404.
15. Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JAR, Perry VH, Weller RO (2008) Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries. Significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol Jan 16 [Epub ahead of print].
16. Castillo GM, Lukito W, Peskind E, Raskind M, Kirschner DA, Yee AG, Snow AD (2000) Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain. J Neurosci Res 62 : 451 462.
17. CFAS NGoM (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357 : 169 175.
18. Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB et al (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer's disease mouse model. J Clin Invest 115 : 3285 3290.
19. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC et al (2005) Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48 : 913 922.
20. Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH et al (2007) A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry 68 : 611 612.
21. Cserr HF, Knopf PM (1992) Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 13 : 507 512.
22. Davson H, Welch K, Segal MB (1987) Physiology and Pathophysiology of the Cerebrospinal Fluid. Churchill Livingstone : Edinburgh.
23. Domnitz SB, Robbins EM, Hoang AW, Garcia-Alloza M, Hyman BT, Rebeck GW et al (2005) Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer's disease. J Neuropathol Exp Neurol 64 : 588 594.
24. Ely M, Melzer D, Opit I, Brayne C (1996) Estimating the numbers and characteristics of elderly people with cognitive disability in local populations. Res Policy Plan 14 : 13 18.
25. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD (1999) Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354 : 919 920.
26. Esiri MM, Lee VMY, Trojanowski JQ (eds 2004) The Neuropathology of Dementia, 2nd edn. Cambridge University Press : Cambridge.
27. Farkas E, De Jong GI, de Vos RA, Jansen Steur EN, Luiten PG (2000) Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. Acta Neuropathol (Berl) 100 : 395 402.
28. Farris W, Schütz SG, Cirrito JR, Shankar GM, Sun X, George A et al (2007) Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Am J Pathol 171 : 241 251.
29. Frackowiak J, Potempska A, LeVine H, Haske T, Dickson D, Mazur-Kolecka B (2005) Extracellular deposits of a beta produced in cultures of Alzheimer's disease brain vascular smooth muscle cells. J Neuropathol Exp Neurol 64 : 82 90.
30. Galea I, Bechmann I, Perry VH (2007) What is immune privilege (not)? Trends Immunol 28 : 12 18.
31. Hardy J (2006) Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis 9 : 151 153.
32. Hardy J (2006) Amyloid double trouble. Nat Genet 38 : 11 12.
33. Hardy J, Cullen K (2006) Amyloid at the blood vessel wall. Nat Med 12 : 756 757.
34. Harling-Berg CJ, Park TJ, Knopf PM (1999) Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J Neuroimmunol 101 : 111 127.
35. Harling Berg C, Knopf PM, Merriam J, Cserr HF (1989) Role of cervical lymph nodes in the systemic humoral immune response to human serum albumin microinfused into rat cerebrospinal fluid. J Neuroimmunol 25 : 2 3.
36. Hart M, Li L, Tokunaga T, Lindsey JR, Hassell JR, Snow AD, Fukuchi K (2001) Overproduction of perlecan core protein in cultured cells and transgenic mice. J Pathol 194 : 262 269.
37. Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD et al (2004) Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7 : 954 960.
38. Herzig MC, Van Nostrand WE, Jucker M (2006) Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 16 : 40 54.
39. Jorm AF, Korten AE, Henderson AS (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76 : 465 479.
40. Kalimo H, Ruchoux M-M, Vitanen M, Kalaria RN (2002) CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 12 : 371 384.
41. Kida S, Pantazis A, Weller RO (1993) CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathol Appl Neurobiol 19 : 480 488.
42. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, Greenberg SM (2007) Course of cerebral amyloid angiopathy-related inflammation. Neurology 68 : 1411 1416.
43. Kisilevsky R, Szarek WA, Ancsin J, Vohra R, Li Z, Marone S (2004) Novel glycosaminoglycan precursors as antiamyloid agents: part IV. J Mol Neurosci 24 : 167 172.
44. Kisilevsky R, Ancsin JB, Szarek WA, Petanceska S (2007) Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications. Amyloid 14 : 21 32.
45. Lake J, Weller RO, Phillips MJ, Needham M (1999) Lymphocyte targeting of the brain in adoptive transfer cryolesion-EAE. J Pathol 187 : 259 265.
46. Lashley T, Holton JL, Verbeek MM, Rostagno A, Bojsen-Møller M, David G et al (2006) Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study. Neuropathol Appl Neurobiol 32 : 492 504.
47. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X et al (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40 : 1087 1093.
48. Levy E, Jaskolski M, Grubb A (2006) The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models. Brain Pathol 16 : 60 70.
49. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L et al (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155 : 853 862.
50. Mann DM, Yates PO, Marcyniuk B (1984) Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol 10 : 185 207.
51. McCarron MO, Nicoll JA, Stewart J, Ironside JW, Mann DM, Love S et al (1999) The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 58 : 711 718.
52. McCarron MO, Nicoll JAR, Stewart J, Ironside JW, Mass DMA, Love S et al (1999) The apolipoprotein E epsilon 2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 58 : 711 718.
53. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K et al (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46 : 860 866.
54. Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG (2006) Decreased expression and activity of neprilysin in Alzheimer's disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol 65 : 1012 1021.
55. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization for the neuropathologic assessment of Alzheimer's disease. Neurology 41 : 479 486.
56. Mueggler T, Rausch M, Meyer-Luehmann M, Staufenbiel M, Jucker M, Rudin M (2004) Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis. Eur J Neurosci 20 : 811 817.
57. Nagasawa S, Handa H, Okumura A, Naruo Y, Moritake K, Hayashi K (1979) Mechanical properties of human cerebral arteries. Part 1: effects of age and vascular smooth muscle activation. Surg Neurol 12 : 297 304.
58. Navarro A, Del Valle E, Astudillo A, González del Rey C, Tolivia J (2003) Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Exp Neurol 184 : 697 704.
59. Nicholas DS, Weller RO (1988) The fine anatomy of the human spinal meninges. A light and scanning electron microscopy study. J Neurosurg 69 : 276 282.
60. Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9 : 448 452.
61. Nicoll JA, Barton E, Boche D, Neal JW, Ferrer I, Thompson P et al (2006) Abeta species removal after Abeta42 immunization. J Neuropathol Exp Neurol 65 : 1040 1048.
62. Nicoll JAR, Yamada M, Frackowiak J, Mazur Kolecka B, Weller RO (2004) Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement. Neurobiol Aging 25 : 589 597.
63. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24 : 1063 1070.
64. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ (1996) The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47 : 190 196.
65. Palsdottir A, Snorradottir AO, Thorsteinsson L (2006) Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects. Brain Pathol 16 : 55 59.
66. Phillips MJ, Needham M, Weller RO (1997) Role of cervical lymph nodes in autoimmune encephalomyelitis in the Lewis rat. J Pathol 182 : 457 464.
67. Preston SD, Steart PV, Wilkinson A, Nicoll JAR, Weller RO (2003) Capillary and arterial amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol 29 : 106 117.
68. Reilly MM, Staunton H (1996) Peripheral nerve amyloidosis. Brain Pathol 6 : 163 177.
69. Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B, Holton JL (2003) Cerebral Amyloid Angiopathies: a Pathologic, Biochemical, and Genetic View. J Neuropathol Exp Neurol 62 : 885 898.
70. Roher AE, Kuo Y-M, Esh C, Knebel C, Weiss N, Kalback W et al (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med 9 : 112 122.
71. Rosand J, Muzikansky A, Kumar A, Wisco JJ, Smith EE, Betensky RA, Greenberg SM (2005) Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol 58 : 459 462.
72. Ruchoux MM, Domenga V, Brulin P, Maciazek J, Limol S, Tournier-Lasserve E, Joutel A (2003) Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol 162 : 329 342.
73. Sagare A, Deane R, Bell RD, Johnson B, Hamm K, Pendu R et al (2007) Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med 13 : 1029 1031.
74. Salzman KL, Osborn AG, House P, Jinkins JR, Ditchfield A, Cooper JA, Weller RO (2005) Giant Tumefactive Perivascular Spaces. Am J Neuroradiol 26 : 298 305.
75. Schley D, Carare-Nnadi R, Please CP, Perry VH, Weller RO (2006) Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol 238 : 962 974.
76. Scholz W (1938) Studien zur Pathologie der Hirngefässe II. Die drusige Entartung der Hirnarterien und -capillaren. (Ein Form seniler Gefässerkrankung). Zeitshrift für die gesamte Neurologie und Psychiatrie 162 : 694 715.
77. Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J et al (2005) Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128 : 500 515.
78. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81 : 741 766.
79. Selkoe DJ (2006) Amyloid beta-peptide is produced by cultured cells during normal metabolism: a reprise. J Alzheimers Dis 9 : 163 168.
80. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B et al (2000) Clearance of Alzheimer's amyloid-beta(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106 : 1489 1499.
81. Shin HK, Jones PB, Garcia-Alloza M, Borrelli L, Greenberg SM, Bacskai BJ et al (2007) Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 130 : 2310 2319.
82. Shinkai Y, Yoshimura M, Ito Y, Odaka A, Suzuki N, Yanagisawa K, Ihara Y (1995) Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 38 : 421 428.
83. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277 : 813 817.
84. Subash M, Weller RO (2003) Cerebral amyloid angiopathy: differential preservation of endothelial cell basement membranes. Neuropath Appl Neurobiol 29 : 184.
85. Sykova E, Vorisek I, Antonova T, Mazel T, Meyer-Luehmann M et al (2005) Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease. Proc Natl Acad Sci USA 102 : 479 484.
86. Szentistvanyi I, Patlak CS, Ellis RA, Cserr HF (1984) Drainage of interstitial fluid from different regions of rat brain. Am J Physiol 246 : F835 F844.
87. Thal DR, Ghebremedhin E, Rub U, Yamaguchi H, Tredici KD, Braak H (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61 : 282 293.
88. Tomura N, Sasaki K, Kidani H, Nishii T, Yasuda K, Ishiyama K et al (2007) Reduced perfusion reserve in leukoaraiosis demonstrated using acetazolamide challenge 123I-IMP SPECT. J Comput Assist Tomogr 31 : 884 887.
89. Tsubuki S, Takaki Y, Saido TC (2003) Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation. Lancet 361 : 1957 1958.
90. Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den Haute C et al (2000) Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. Am J Pathol 157 : 1283 1298.
91. van Horssen J, Otte-Höller I, David G, Maat-Schieman ML, van den Heuvel LP, Wesseling P et al (2001) Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. Acta Neuropathol (Berl) 102 : 604 614.
92. Walsh DM, Selkoe DJ (2007) Abeta oligomers - a decade of discovery. J Neurochem 101 : 1172 1184.
93. Walsh DM, Minogue AM, Sala Frigerio C, Fadeeva JV, Wasco W, Selkoe DJ (2007) The APP family of proteins: similarities and differences. Biochem Soc Trans 35 : 416 420.
94. Weller RO (1995) Fluid compartments and fluid balance in the central nervous system. In : Gray's Anatomy, 38th edn. PL Williams (eds), pp. 1202 1224. Churchill Livingstone : Edinburgh.
95. Weller RO (1998) Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J Neuropathol Exp Neurol 57 : 885 894.
96. Weller RO (2005) Microscopic morphology and histology of the human meninges. Morphologie 89 : 22 34.
97. Weller RO, Nicoll JA (2005) Cerebral amyloid angiopathy: both viper and maggot in the brain. Ann Neurol 58 : 348 350.
98. Weller RO, Nicoll JAR (2003) Cerebral Amyloid Angiopathy: pathogenesis and effects on the ageing and Alzheimer brain. Neurol Res 25 : 611 616.
99. Weller RO, Wisniewski H (1969) Histological and ultrastructural changes with experimental hydrocephalus in adult rabbits. Brain 92 : 819 828.
100. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE (1998) Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 153 : 725 733.
101. Wilcock DM, Rojiani A, Rosenthal A, Subbarao S, Freeman MJ, Gordon MN, Morgan D (2004) Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation 1 : 24.
102. Wisniewski HM, Wegiel J (1994) Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol (Berl) 87 : 233 241.
103. Wu CC, Mungas D, Eberling JL, Reed BR, Jagust WJ (2002) Imaging interactions between Alzheimer's disease and cerebrovascular disease. Ann NY Acad Sci 977 : 403 410.
104. Wyss Coray T, Lin C, Sanan DA, Mucke L, Masliah E (2000) Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am J Pathol 156 : 139 150.
105. Zhang WW, Lempessi H, Olsson Y (1998) Amyloid angiopathy of the human brain: immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells. Acta Neuropathol (Berl) 96 : 558 563.
106. Zhang-Nunes SX, Maat-Schieman ML, van Duinen SG, Roos RA, Frosch MP, Greenberg SM (2006) The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol 16 : 30 39.